Biomarker identification, selection and clinical validation presents many challenges. We can help you solve them.
Biomarkers are pivotal in diagnostics and drug development. Are you finding the most sensitive, specific, and reproducible multi-marker signatures?
Ariana helps you develop robust biomarker signatures and find the best combinations of biomarkers in your data. It’s the only FDA-tested technology that explores the entire combinatorial space to supply you with the best, most cost-effective signatures.
We deliver the actionable information you need to support your development processes: with our KEM® (Knowledge, Extraction, Management) process, we integrate and analyze multi-parametric data to provide you with the most relevant combinations of markers and patient characteristics.
Our platform handles any kind of relevant data you provide, including clinical, imaging, biochemical, NGS/genomic/proteomic/transcriptomic, genetic, patient characteristics and more.
Identify, optimize and rank your biomarker signatures.
Find the best companion markers.
Minimize data overfitting and bias.
Mine your databases and identify associations between your biomarkers to support your decision processes.
Save money by reducing the number of parameters you need to measure.